IRIS
TOCCHETTI, CARLO GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.294
NA - Nord America 8.682
EU - Europa 6.899
SA - Sud America 1.189
AF - Africa 322
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 27.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.361
SG - Singapore 4.519
RU - Federazione Russa 3.016
CN - Cina 1.942
VN - Vietnam 1.793
IT - Italia 1.567
HK - Hong Kong 961
BR - Brasile 946
DE - Germania 439
FR - Francia 399
FI - Finlandia 308
NL - Olanda 281
CA - Canada 184
IN - India 180
JP - Giappone 176
GB - Regno Unito 161
BD - Bangladesh 158
UA - Ucraina 143
SE - Svezia 127
IE - Irlanda 103
AR - Argentina 96
KR - Corea 91
CI - Costa d'Avorio 88
ZA - Sudafrica 79
MX - Messico 72
IQ - Iraq 67
PH - Filippine 64
ES - Italia 53
AT - Austria 48
PL - Polonia 48
EC - Ecuador 45
ID - Indonesia 39
PK - Pakistan 36
TH - Thailandia 36
TR - Turchia 35
TW - Taiwan 34
LT - Lituania 33
PT - Portogallo 31
CO - Colombia 30
EG - Egitto 25
VE - Venezuela 25
BE - Belgio 24
KE - Kenya 19
MA - Marocco 18
BG - Bulgaria 17
DZ - Algeria 17
UZ - Uzbekistan 17
NG - Nigeria 16
IL - Israele 15
SK - Slovacchia (Repubblica Slovacca) 14
NP - Nepal 13
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
AZ - Azerbaigian 11
CL - Cile 11
PE - Perù 11
PY - Paraguay 11
DO - Repubblica Dominicana 10
JO - Giordania 10
MY - Malesia 10
CH - Svizzera 9
ET - Etiopia 9
JM - Giamaica 9
LB - Libano 9
RO - Romania 9
CZ - Repubblica Ceca 8
GE - Georgia 8
GR - Grecia 8
HR - Croazia 8
IR - Iran 8
TT - Trinidad e Tobago 8
KZ - Kazakistan 7
BO - Bolivia 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
RS - Serbia 6
SA - Arabia Saudita 6
UY - Uruguay 6
AL - Albania 5
AM - Armenia 5
DK - Danimarca 5
LV - Lettonia 5
NI - Nicaragua 5
OM - Oman 5
PS - Palestinian Territory 5
AO - Angola 4
CR - Costa Rica 4
CY - Cipro 4
GT - Guatemala 4
HT - Haiti 4
KW - Kuwait 4
PA - Panama 4
BB - Barbados 3
BH - Bahrain 3
BJ - Benin 3
BW - Botswana 3
HN - Honduras 3
LC - Santa Lucia 3
MD - Moldavia 3
Totale 27.337
Salva come PNG Salva come JPEG
Città #
Singapore 2.179
San Jose 1.435
Hong Kong 940
Ashburn 800
Chandler 779
Moscow 730
Beijing 493
Ho Chi Minh City 487
Hefei 416
Hanoi 369
Naples 304
Santa Clara 303
The Dalles 287
Lauterbourg 250
Los Angeles 237
Amsterdam 216
Millbury 187
Boston 162
Council Bluffs 158
Nanjing 155
Des Moines 145
Tokyo 142
Princeton 132
New York 121
Munich 120
Dallas 114
Buffalo 110
Wilmington 109
Redondo Beach 106
Jacksonville 105
São Paulo 97
Da Nang 87
Dong Ket 86
Lawrence 86
Haiphong 79
Frankfurt am Main 77
Seoul 75
Helsinki 73
Napoli 70
Lappeenranta 67
Seattle 67
Milan 65
Ottawa 63
Orem 59
Rome 57
Woodbridge 55
Nuremberg 54
Turku 54
Chicago 48
Houston 45
Hebei 40
Montreal 40
Nanchang 39
Atlanta 38
Warsaw 38
Mexico City 37
Denver 36
London 36
Brooklyn 35
Falkenstein 34
Shenyang 33
Toronto 33
Pune 32
Stockholm 31
Belo Horizonte 28
Hải Dương 28
Palermo 26
Can Tho 25
Johannesburg 25
Kochi 25
Phoenix 25
Rio de Janeiro 25
Washington 25
Chennai 24
Guangzhou 24
Biên Hòa 23
Bologna 23
Caserta 23
Changsha 23
Dublin 23
Norwalk 23
Boardman 22
Tianjin 22
Turin 22
Fairfield 20
Shanghai 20
Dearborn 19
Jiaxing 19
Baghdad 18
Brasília 18
Charlotte 18
Guayaquil 18
Poplar 18
Salt Lake City 18
Dhaka 17
Hangzhou 17
Manchester 17
San Francisco 17
Fortaleza 16
Madrid 16
Totale 14.727
Salva come PNG Salva come JPEG
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 742
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 202
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 188
Antineoplastic drug-induced cardiotoxicity: A redox perspective 183
Right ventricular failure in left heart disease: from pathophysiology to clinical manifestations and prognosis 180
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 180
Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure 176
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production 167
Myocardial collagen turnover in hypertrophic cardiomyopathy 165
Adapted recreational football Small Sided Games improves cardiac capacity, body composition and muscular fitness in patients with type 2 diabetes: results from a pilot study 162
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients 161
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 160
Dobutamine stress echocardiography in hypertrophic cardiomyopathy 160
Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 160
Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes 159
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 158
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 158
Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed 157
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects 154
Mitral peak early diastolic filling velocity to deceleration time ratio as a predictor of prognosis in patients with chronic heart failure and preserved or reduced ejection fraction. 153
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 152
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC Working Group on Cellular Biology of the Heart 151
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 151
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 150
Cardiotoxicity of immune checkpoint inhibitors 150
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 149
Oxidative stress in anticancer therapies-related cardiac dysfunction 149
Prevention of cardiovascular complications in elderly cancer patients 149
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue 147
Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. 145
The role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a Position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC) 144
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 142
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 140
Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities 139
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 139
An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology 138
Biomarkers in sarcopenia: A multifactorial approach. 138
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 138
A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial 137
European Society of Cardiology Core Curriculum for Cardio-Oncology 136
Editorial: Myocardium regeneration and cardioprotection 136
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus 136
The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology 135
Severe Aortic Valve Regurgitation in Relapsing Polychondritis 135
The Influence of Fiber on Gut Microbiota: Butyrate as Molecular Player Involved in the Beneficial Interplay Between Dietary Fiber and Cardiovascular Health 135
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) 134
The innate immune system in chronic cardiomyopathy: A European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC 134
Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 134
Complex Roads from Genotype to Phenotype in Dilated Cardiomyopathy: Scientific update from the Working Group of Myocardial Function of the European Society of Cardiology 134
Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. 133
Permanent atrial fibrillation and pulmonary embolism in elderly patients without deep vein thrombosis: is there a relationship? 132
Common Mechanistic Pathways in Cancer and Heart Failure 132
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 132
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 130
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 130
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 129
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 128
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology 128
Priorities in Cardio-Oncology Basic and Translational Science 127
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 127
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 127
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 127
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 126
Hemodynamic effects of isometric exercise in hypertrophic cardiomyopathy: comparison with normal subjects 126
Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy 126
Cardiovascular events and treatment of children with high risk medulloblastoma 126
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 125
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. 125
Myocardial collagen turnover in hypertrophic cardiomyopathy 125
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs 124
Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 123
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 123
Phosphoinositide 3-Kinase Gamma Inhibition Protects from Anthracycline Cardiotoxicity and Reduces Tumor Growth 123
Novel Therapeutic Approaches and Targets for the Treatment of Cardiovascular and Immunological Diseases 123
Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure 123
Nitroxyl: A positive inotrope enhancing SR CA(2+) cycling in isolated myocytes 122
Targeting fibrosis in the failing heart with nanoparticles. 122
'Circulating' RNA-based therapies in Cardio-Oncology 121
Physical vs. multidimensional frailty in older adults with and without heart failure 121
Editorial: Novel Therapeutic Strategies for the Treatment of Chronic Diseases 120
Reciprocal organ interactions during heart failure-a position paper from the ESC working group on myocardial function 119
Epidemiology, Pathophysiology, Diagnosis and Management of Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 118
The continuous heart failure spectrum: moving beyond an ejection fraction classification 118
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis 118
Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart 118
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 118
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 117
The broad spectrum of cardiotoxicities from immunotherapies 116
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 116
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better 114
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology 114
Time-weighted lactate as a predictor of adverse outcome in acute heart failure 113
Aldose Reductase Inhibition or Activation of Transketolase Offset Adverse Metabolic Remodeling Improving Function in Type 2 Diabetes Myocytes Exposed to Hyperglycemia 112
Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond 111
Treatments targeting inotropy 111
Utility of 2D-speckle tracking echocardiography in diagnosis of left ventricular dysfunction in anti-ErbB2 therapy 110
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 110
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology 110
Education and Certification on Heart Failure of the Heart Failure Association of the European Society of Cardiology 110
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 110
Totale 14.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.069
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/20221.132 31 4 15 21 30 32 42 62 101 100 190 504
2022/20232.192 251 122 84 176 273 209 58 258 381 240 105 35
2023/20241.527 47 190 230 115 89 216 72 184 29 48 213 94
2024/20257.219 352 438 40 62 141 443 701 508 609 764 2.481 680
2025/202613.850 1.492 1.079 1.421 1.211 2.267 580 1.782 872 1.563 1.001 473 109
Totale 27.974